Global and promoter specific hypermethylation of tumor suppressor genes P16, SOCS1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Aberrant methylation patterns in tumor suppressor genes are linked to oral cancer progression. This study found significant differences in promoter and global methylation between oral squamous cell carcinoma (OSCC), oral submucous fibrosis (OSMF), and healthy controls, suggesting methylation load as a potential biomarker.
Area Of Science
- Oncology
- Epigenetics
- Molecular Biology
Background
- Aberrant DNA methylation patterns are implicated in cancer development, including oral squamous cell carcinoma (OSCC).
- Previous research on tumor suppressor gene methylation (P16, SOCS1, SHP1) in cancers often relied on in-vitro or animal models, with limited human sample data.
- Oral submucous fibrosis (OSMF) is a precancerous condition, and understanding its molecular transition to OSCC is crucial.
Purpose Of The Study
- To investigate the association between global and promoter-specific methylation of tumor suppressor genes (P16, SOCS1, SHP1) in patients with OSCC and OSMF.
- To compare methylation patterns in human blood and tissue samples from OSCC patients, OSMF patients, and healthy controls.
- To explore the potential of methylation load as a minimally invasive biomarker for oral cancer progression.
Main Methods
- Quantitative PCR (qPCR) was used to evaluate promoter-specific methylation of P16, SOCS1, and SHP1 in 76 OSCC and OSMF patient samples and 35 healthy controls.
- ELISA was employed to analyze global methylation patterns (%mC) in the same sample groups.
- Correlation analysis was performed to assess the relationship between methylation indices, global methylation, and risk factors like tobacco, smoking, and alcohol consumption.
Main Results
- A significant decreasing trend in promoter methylation was observed: OSCC > OSMF > Controls.
- Methylation indices (MI) for P16, SHP1, and SOCS1 were significantly higher in OSCC patients compared to controls.
- Global methylation (%mC) values were markedly higher in OSCC (1.9) and OSMF (0.5) compared to controls (0.1).
- Methylation levels in tissue samples were reflected in blood samples, indicating potential for blood-based biomarkers.
- Methylation load correlated with risk factors (tobacco, smoking, alcohol) and showed reasonable sensitivity and specificity.
Conclusions
- Global and promoter-specific methylation of tumor suppressor genes P16, SOCS1, and SHP1 play a role in the transition from OSMF to OSCC.
- Methylation load in blood samples could serve as a promising, less invasive biomarker for monitoring oral cancer progression.
- Further research is warranted to validate these findings and explore therapeutic interventions targeting epigenetic modifications.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...